Neurogenic Detrusor Overactivity
📧 Sign up to get email alerts when something new happens for Neurogenic Detrusor Overactivity.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-03-06Clinical Trial Update: A Study to Learn How Effective and Safe the Drug 'Mirabegron' is and How Long it Stays in the Body of Children Aged 6 Months to Less Than 3 Years of Age With Neurogenic Detrusor Overactivity [Phase 3]
Phase 3 clinical trial update evaluating the safety, effectiveness, and pharmacokinetics of mirabegron in young children with neurogenic det…
-
CLINICAL_TRIALS research · 2026-02-05Clinical Trial Update: Dose Escalation Study of EG110A, Administered by Intradetrusor Injections to Adults With Neurogenic Detrusor Overactivity-related Incontinence Following Spinal Cord Injury Who Regularly Perform Clean Intermittent Catheterization [Phase 1, Phase 2]
Phase 1/2 dose-escalation study of EG110A delivered via intradetrusor injections for neurogenic detrusor overactivity related to spinal cord…
-
CLINICAL_TRIALS research · 2025-03-14Clinical Trial Update: Improving Pelvic Rehabilitation Using Epidural Stimulation After Spinal Cord Injury [NA]
This clinical trial update describes a University College London study testing epidural stimulation to improve pelvic rehabilitation after s…
-
CLINICAL_TRIALS research · 2024-07-03Clinical Trial Update: A Study of Vibegron in Pediatric Participants 2 Years to Less Than (<) 18 Years of Age With NDO and on CIC [Phase 2, Phase 3]
A pediatric study of vibegron for neurogenic detrusor overactivity in children aged 2 to less than 18 years is currently recruiting, coverin…
-
CLINICAL_TRIALS research · 2024-04-26Clinical Trial Update: Dorsal Genital Nerve Stimulation for Bladder Management After SCI [NA]
Clinical trial update on Dorsal Genital Nerve Stimulation for bladder management after spinal cord injury; the study is currently active but…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2016-05-17Clinical Trial Update: Heart Rate Variability (HRV) in Patients With Neurogenic Detrusor Overactivity (NDO) Before and After Botulinum Neurotoxin Type A (BoNT/A) Intradetrusor Injections
This completed clinical trial evaluated heart rate variability in patients with neurogenic detrusor overactivity before and after intradetru…